RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sripal Bangalore

Interventional Cardiology · New York, NYNPI 1902066871

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Mylan Inc. at 40.5% of the total. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$481,580in general payments, 2019–2025

Across 486 payments — averaging $990.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Inc.$195K
  • Abbott$60K
  • Inari Medical, Inc.$39K
  • Imperative Care, Inc$30K
  • Angiodynamics, Inc.$29K
  • Boston Scientific$20K
  • plus $109K from 19 others
$317,676in research payments, 2019–2025

Across 106 payments — averaging $2996.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Recor Medical Inc$100K
  • Imperative Care, Inc$79K
  • Penumbra, Inc.$66K
  • Biotronik Inc.$50K
  • Abbott$22K

What the payments were for

  • Consulting fees$276,65357%
  • Speaking & faculty fees$107,93722%
  • Travel & lodging$81,80217%
  • Food & beverage$15,1893%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mylan Inc.160$194,901
Abbott54$59,976
Inari Medical, Inc.55$38,926
Imperative Care, Inc24$29,508
Angiodynamics, Inc.49$28,775
Boston Scientific41$20,322
Stryker12$17,912
Amgen19$16,403
Shockwave Medical, Inc13$13,821
Truvic Medical, Inc.8$13,107
Biotronik Inc.12$12,319
Boehringer Ingelheim MENA (scientific Office) Fz-llc3$12,266
Recor Medical Inc14$10,568
Pfizer1$3,500
Merck1$3,355
Magenta Medical Inc4$2,250
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$2,000
Argon Medical Devices, Inc.3$645
Terumo Medical Corporation1$350
Medtronic4$241
ZOLL Circulation Inc1$239
Abiomed2$64
Cardiva Medical, Inc.2$63
W. L. Gore & Associates, Inc.1$34
Siemens Medical Solutions USA, Inc.1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$481,580 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$13,533
Medicare patients
13
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →